View in EDS

Dulaglutide as a demethylating agent to improve the outcome of breast cancer.

Saved in:

Bibliographic Details
Title:	Dulaglutide as a demethylating agent to improve the outcome of breast cancer.
Authors:	Tatsch JM; Department of Basic Pathology, Laboratory of Epigenetics, Federal University of Paraná, Curitiba, PR, Brazil., Furman DP; Department of Basic Pathology, Laboratory of Epigenetics, Federal University of Paraná, Curitiba, PR, Brazil., Nobre RM; Department of Basic Pathology, Laboratory of Epigenetics, Federal University of Paraná, Curitiba, PR, Brazil., Wurzer KM; Department of Basic Pathology, Laboratory of Epigenetics, Federal University of Paraná, Curitiba, PR, Brazil., da Silva LC; Department of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil., Picheth GF; Department of Biochemistry Federal University of Paraná, Curitiba, PR, Brazil., Ramos EA; Department of Basic Pathology, Laboratory of Epigenetics, Federal University of Paraná, Curitiba, PR, Brazil., Acco A; Department of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil., Klassen G; Department of Basic Pathology, Laboratory of Epigenetics, Federal University of Paraná, Curitiba, PR, Brazil.
Source:	Epigenomics [Epigenomics] 2023 Dec; Vol. 15 (24), pp. 1309-1322. Date of Electronic Publication: 2024 Jan 04.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Taylor & Francis Country of Publication: England NLM ID: 101519720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-192X (Electronic) Linking ISSN: 1750192X NLM ISO Abbreviation: Epigenomics Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1750-192X
DOI:	10.2217/epi-2023-0332